沃特世公司将在Citi 2013全球医疗保健大会上进行演示，并通过AOL.com进行网络直播。
Waters Corporation Presentation at the Citi 2013 Global Healthcare Conference to Be Webcast Live - AOL.com
生命科学资讯
生物技术与制药领域的最新动态
#ASH25：Star Therapeutics公布血液疾病注射剂早期数据，并考虑IPO。
#ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO
龙沙集团增长倚重生物制剂，但风险犹存——Finimize
Lonza’s Growth Hinges On Biologics, But Risks Remain - Finimize
ASH：随着吉利德旗下Kite公司准备上市，Anito-cel强化了其最佳潜力。
ASH: Anito-cel strengthens best-in-class potential as Gilead's Kite preps for launch
在ASH大会上，礼来力推Jaypirca在白血病和淋巴瘤中的更广泛应用。
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
ASH：明星抗体在潜在三期出血性疾病成功预演中闪耀。
ASH: Star antibody sparkles in preview of potential phase 3 bleeding disease success
高通量筛选市场主要企业展望至2035年 | 安捷伦科技 - openPR.com
High Throughput Screening Market Top key Players 2035 | Agilent - openPR.com
Illumina（ILMN）分析师盈利预测上调将如何影响投资者 - simplywall.st
How Illumina’s (ILMN) Analyst Earnings Upgrade Will Impact Investors - simplywall.st
Jump Financial LLC购入38,298股赛默飞世尔科技公司股票$TMO - MarketBeat
Jump Financial LLC Purchases 38,298 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cary Street Partners Financial LLC减持赛默飞世尔科技股份 $TMO - 市场脉搏
Cary Street Partners Financial LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
谁拥有赛默飞世尔科技？主要股东及近期内部交易 - TIKR.com
Who Owns Thermo Fisher Scientific? Top Shareholders and Recent Insider Trades - TIKR.com
迷幻蘑菇素触发大规模皮层网络的活动依赖性重构
Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks
赛默飞世尔科技(NYSE:TMO)首席运营官减持22,046股股份 - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) COO Sells 22,046 Shares - MarketBeat
#ASH25：阿斯利康双靶点CAR-T疗法在西方患者中疗效与中国患者相当
#ASH25: AstraZeneca's dual-targeting CAR-T sees similar responses in Western patients as in China
安捷伦科技股票能否承受更多下行压力？- Trefis分析
Is Agilent Technologies Stock Built to Withstand More Downside? - Trefis
摩根士丹利降级后10x Genomics股价下跌5.5%，牛市逻辑是否生变？
10x Genomics (TXG) Is Down 5.5% After Morgan Stanley Downgrade Has The Bull Case Changed? - simplywall.st
#ASH25：再生元淋巴瘤双特异性药物一扇门关闭，另一扇门开启
#ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens
安捷伦科技公司（NYSE:A）近期股价表现是否与其强劲的基本面紧密相连？ - 雅虎财经
Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Vertex基因编辑疗法在儿童血液疾病治疗中取得早期目标
Vertex CRISPR therapy hits early goal in children with blood disorders
ASH 2025：Casgevy能否用于儿童？镰状细胞病基因疗法的扩展与优化
ASH 2025: Casgevy for kids? Expanding, improving SCD gene therapies